420 with CNW — New Study Suggests CBD May Increase Your

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
303
420 with CNW — New Study Suggests CBD May Increase Your Lifespan

As 2018 drew to a close, Congress passed a bill that finally legalized industrial hemp after years of prohibition. Among other things, the 2018 Farm Bill legalized the cultivation and sale of industrial hemp plus its extracts. Soon after, demand for a hemp extract called cannabidiol (“CBD”) boomed to immense heights, based mostly on claims that it had extensive medical benefits. Subsequent studies have found CBD to indeed be effective against everything from anxiety, stress, and insomnia to chronic pain and pediatric epilepsy.

While CBD has been proven to be effective against a wide range of medical conditions, does it have the ability to actually increase your lifespan? According to the results of a new study, hemp extract actually may be able to help you live longer. A study by Canopy Group Corporation concluded that worms that consume CBD had a longer lifespan compared to worms that didn’t. Consuming hemp-derived CBD increased the overall lifespan of the worms by 20% and their late-stage activities by 200%.

Additionally, the worms did not exhibit signs of prolonged lifespan toxicity, which refers to the negative side effects of sustained exposure to a stressor. However, note that these results were from an animal study, so more research, specifically on the effect of long-term CBD use by humans, is needed. Still, the fact that cannabidiol increased the worms’ lifespan by 20% without causing any chronic toxicity is impressive.

Nonetheless, translating the methods used in this study for human research will prove difficult. Since worms have a lifespan of only two to three weeks, researchers had enough time to monitor the worms and document how CBD affected their lifespans. On the other hand, humans have a much longer lifespan, making the prospect of studying the long-term effects of CBD consumption on their lifespan more daunting. Fortunately, human and worm genes are quite similar, so the preclinical model used by the Canadian Cannabis Grower’s Association can be used for human studies.

The researchers’ objective was to find out how long-term CBD use affected the worms, especially in regards to solubility, acute toxicity and stability. The researchers found continued CBD use to be safe from any acute toxicity, with none of the worms dying that were exposed to acute CBD. In fact, exposure to concentrated CBD had the opposite effect and extended their lifespans.

A separate study by the University of Bonn looked at the effect of CBD on the memory performance of older mice and found that cannabis had the ability to reverse aging in the brain. Future studies will be needed to concretely prove cannabis’ effect on patients with Alzheimer’s disease.

This research pointing to the potential of CBD to extend human life gives the innovative products of many cannabis companies added value. For example, California-based Grapefruit USA Inc. (OTCQB: GPFT) has technology that makes topically administered CBD more absorbable, thereby increasing the likelihood that a user will get maximum benefit from the cannabis compound.

NOTE TO INVESTORS: The latest news and updates relating to Grapefruit USA Inc. (OTCQB: GPFT) are available in the company’s newsroom at http://cnw.fm/GPFT

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

GRAPEFRUIT USA INC. (GPFT) Stock Research Links

GPFT Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ractigen's LiCO™ Platform Hits Extrahepatic Milestones

Updated Category News Views 27

Breaking New Ground in RNA Therapeutics Hey, in the world of biotech, landing a meaningful delivery system is like striking gold, and it seems Ractigen Therapeutics just found a shiny nugget. Their latest study on the LiCO™ platform, living and breathing in the pages of Molecular Therapy - Nucleic Acids, maps out a path to some serious therapeutic territory. These guys...

Continue Reading
Divorce Expertise: Obenhaus Adds CDFA Credential

Updated Category News Views 46

Divorce isn't just a legal tangled mess; it's a financial minefield as well. Lindsey Obenhaus from Goranson Bain Ausley has beefed up her credentials with a Certified Divorce Financial Analyst® (CDFA®) designation, lending a sharper edge to her approach in divorce financials. When relationships turn sour, so do wallets, and Obenhaus aims to soften that blow for her...

Continue Reading
Veterans Find Community and Wellness at Orland Hills Bash

Updated Category News Views 16

A Celebration of Veterans and Community Orland Hills is set to light up with a unique Veterans Day Bash on November 1, 2026. This isn't just your run-of-the-mill community gathering; it's an event that brings together veterans from all around for a day packed with resources, education, and a chance to connect with kindred spirits—all thanks to the collaboration between...

Continue Reading
Enigmata Innovates AI Security with Finovifi Tie-Up

Updated Category News Views 94

Emerging AI Risks and Protective Measures AI in financial spaces is like walking a tightrope, there's potential but caution is crucial. Enter Enigmata, diving headfirst into this arena by shaking hands with the Finovifi Marketplace. Their aim? To bolster AI's promise without letting sensitive data slip through the cracks. Sentinel: A New Guard for Sensitive Data Let's not...

Continue Reading
Medicare Limits and Long-Term Care Planning Tips

Updated Category News Views 36

Grappling with Medicare's Gaps Most folks hear Medicare and feel a sigh of relief—thinking it's a catch-all net for healthcare in your golden years. But hold on, when it comes to long-term care, Medicare's got more holes than Swiss cheese. Cindy Couyoumjian from Cinergy Financial lays it out pretty clear: Medicare doesn't cover what it calls 'custodial care'—you know,...

Continue Reading
Lincoln Educational Faces Investor Lawsuit Over Revenue Drop

Updated Category News Views 70

Investors Face Rough Waters Okay, let’s dive into this latest mess at Lincoln Educational Services Corp. (NASDAQ:LINC). Things aren't smelling too rosy over at their headquarters. If you've got shares here, you’ll know what I mean. Back in early May, the folks running Lincoln threw a garden party talking up a 19.5% growth in student starts. Who wouldn’t get behind...

Continue Reading
Amy Johnson Steps Up as GDIT President Amid Shifts

Updated Category News Views 68

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Continue Reading
Podcast Giants Converge in Tennessee for POD U Summit

Updated Category News Views 69

Nashville Becomes a Hotspot for Podcasters Amidst the strumming guitars and honky-tonk vibes of Nashville, Tennessee transformed into the epicenter of podcasting innovation thanks to Rebel Audio's inaugural summit, POD U. Here we had big names like Mike 'Big Mike' Majlak rubbing shoulders with sports experts and media moguls—a true concoction of voices shaping the...

Continue Reading
Dimethylaminopropylamine Market Eyes $732M by 2035

Updated Category News Views 21

Surfactants and Epoxy Fuel Dimethylaminopropylamine Demand Hot off the presses, folks! Dimethylaminopropylamine, or DMAPA if you're into acronyms, is gearing up for a steady climb to a $731.9 million market value by the year 2035. That's quite the leap from the $452.6 million we saw back in 2025. According to Credence Research's latest estimates, this amine is hitching...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 93

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading

Top 5 Most Recently Viewed Articles

Infosys and Sally Beauty Forge Groundbreaking IT Partnership

Updated Category News Views 165

Infosys has officially linked arms with Sally Beauty Holdings, Inc. to kick off a major IT transformation initiative. The aim? Ramp up enterprise-scale efficiencies through hyper-automation, putting Sally Beauty on the fast track for growth and keeping it competitive in a crowded beauty sector. You know how it goes when firms try to modernize—it's always a mixed bag,...

Continue Reading
HYLENR and TakeMe2Space Join Forces for Space Innovation

Updated Category News Views 324

HYLENR and TakeMe2Space Team Up for Space Exploration HYLENR Technologies, a frontrunner in clean energy solutions, has embarked on an exciting collaboration with the innovative space-tech company, TakeMe2Space. This partnership aims to explore the potential of Low-Energy Nuclear Reaction (LENR) technology for space-based computing infrastructures. Innovative...

Continue Reading
Convoy of Hope Sets Goal to Deliver Millions of Meals

Updated Category News Views 294

Convoy of Hope's Major Initiative to Support Families As families across America face difficulties in making ends meet, there's a growing need for assistance. For just $10, it's possible to provide 30 meals to those in need. Feeding Families Nationwide In response to the increasing needs of these families, Convoy of Hope has launched an impressive initiative to deliver 10...

Continue Reading
Transforming Diets: Pulses Market Growth and Insights

Updated Category News Views 207

The Flourishing Pulses Market Driven by Plant-Based Demand The global pulses market is experiencing significant growth, with projections estimating its value to rise from USD 78.0 billion in the coming years to USD 135.2 billion. This increase represents an impressive CAGR of 5.7% throughout the forecast period. The motivation behind this expansion is largely attributed...

Continue Reading
Understanding Windtree's New Istaroxime Patent for Heart Treatments

Updated Category News Views 123

Windtree's Istaroxime Patent Issuance: A Game Changer for Heart Failure Windtree Therapeutics, Inc., a pioneering biotech firm, recently celebrated a watershed moment with the issuance of a patent for istaroxime by the United States Patent and Trademark Office. This patent pertains to a unique intravenous formulation aimed at treating acute heart failure, an ailment that...

Continue Reading